The present invention relates to tetrahydroprotoberberines of the formula (I) and the physiologically acceptable salts thereof. The invention also relates to the use of the compounds of the formula (I) or pharmaceutically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with dopamine receptor ligand, such as schizophrenia.
本发明涉及式(I)的四氢原咯啉和其生理学上可接受的盐。该发明还涉及使用式(I)的化合物或其药理学上可接受的盐制备用于治疗可通过
多巴胺受体
配体治疗的医疗疾患的药物组合物。